← The Wire
ODTXNasdaq
Odyssey Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1882782
Developing precise medicines for autoimmune and inflammatory diseases by targeting the innate immune system
$797M
Market cap
$18.89
Last close
+4.6%
1D
+0.9%
5D
389K
Volume
Price · last 35 sessions+15.0%
May 8L $16.20 · H $19.07Jun 29
8
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureJun 23, 202610-Q10-QJun 17, 20268-KResults of OperationsJun 17, 2026SC 13DSC 13DMay 18, 2026SC 13DSC 13DMay 18, 2026SC 13DSC 13DMay 15, 2026SC 13DSC 13DMay 15, 20268-KMaterial Agreement · Equity IssuanceMay 11, 2026424B4424B4May 8, 2026S-1/AS-1/AMay 4, 2026S-1S-1Apr 17, 2026S-1S-1Jan 17, 2025
Similar companies
Comparable business profile · signals at a glance